SCHEMBL3265344

SCHEMBL3265344

O=Cc1cc2ccc(O)c(Cl)c2oc1=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 7/20 0.49
ESR1 P03372 4/20 0.46
ESR2 Q92731 4/20 0.46
KDM4E B2RXH2 1/20 0.41
MEN1 O00255 1/20 0.41
ALDH1A1 P00352 1/20 0.41
MAPT P10636 1/20 0.41
HPGD P15428 1/20 0.41
KMT2A Q03164 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
CSNK2A2 P19784 1/20 0.40
CSNK2B P67870 1/20 0.40
CSNK2A1 P68400 1/20 0.40
ADORA3 P0DMS8 3/20 0.39
ADORA2A P29274 3/20 0.39
ADORA1 P30542 3/20 0.39
MGAM O43451 1/20 0.38
GAA P10253 1/20 0.38
SI P14410 1/20 0.38
MGAM2 Q2M2H8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1861170 0.85 ADORA2A (0.54) ERN1KDM4EMEN1ALDH1A1MAPT
SCHEMBL28058893 0.74 CSNK2A2 (0.58) ESR1ESR2KDM4EALDH1A1MAPT
SCHEMBL3262155 0.72 NPSR1 (0.45) ERN1ESR1ESR2KDM4EMEN1
SCHEMBL5867251 0.71 GPR35 (0.55) ERN1KDM4EMEN1ALDH1A1MAPT
SCHEMBL1861098 0.71 HSD17B3 (0.60) ESR2KDM4EMEN1ALDH1A1MAPT
SCHEMBL28066198 0.68 TYR (0.51) ERN1ESR1ESR2HPGDADORA3
SCHEMBL31300223 0.68 ERN1 (0.54) ERN1KDM4EMEN1ALDH1A1MAPT
SCHEMBL219677 0.68 ERN1 (0.54) ERN1KDM4EMEN1ALDH1A1MAPT
SCHEMBL11585942 0.67 ALDH1A1 (0.57) KDM4EMEN1ALDH1A1MAPTHPGD
SCHEMBL6828285 0.67 ESR2 (0.68) ESR1ESR2CSNK2A2CSNK2BCSNK2A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100029017-A1 Mono-chlorinated hydroxycoumarin conjugates BECTON, DICKINSON AND COMPANY 2010-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029017-A1 Mono-chlorinated hydroxycoumarin conjugates CLSPN, CLTC, HACD3 ERN1 4838/4885ESR1 3963/4885ESR2 4317/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.